Comvita Limited, together with its subsidiaries, engages in manufacturing and marketing natural health products in Australia, New Zealand, China, rest of Asia, North America, Europe, the Middle East, Africa, and internationally.
Price History & Performance
|Historical stock prices|
|Current Share Price||NZ$3.73|
|52 Week High||NZ$3.06|
|52 Week Low||NZ$3.80|
|1 Month Change||3.32%|
|3 Month Change||13.03%|
|1 Year Change||11.34%|
|3 Year Change||-36.57%|
|5 Year Change||-60.53%|
|Change since IPO||69.55%|
Recent News & Updates
These 4 Measures Indicate That Comvita (NZSE:CVT) Is Using Debt Reasonably Well
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
|CVT||NZ Personal Products||NZ Market|
Return vs Industry: CVT underperformed the NZ Personal Products industry which returned 23% over the past year.
Return vs Market: CVT exceeded the NZ Market which returned 2.1% over the past year.
Stable Share Price: CVT is not significantly more volatile than the rest of NZ stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: CVT's weekly volatility (3%) has been stable over the past year.
About the Company
Comvita Limited, together with its subsidiaries, engages in manufacturing and marketing natural health products in Australia, New Zealand, China, rest of Asia, North America, Europe, the Middle East, Africa, and internationally. The company offers Manuka honey, propolis, olive leaf extract, medihoney and skincare, gourmet honey, elixirs and lozenges, and cider vinegar products, as well as oral and kids health products. It also provides solutions for digestive health, eczema prone skin, energy, heart health, and immune support, as well as for summer and travel essentials.
Comvita Fundamentals Summary
|CVT fundamental statistics|
Is CVT overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|CVT income statement (TTM)|
|Cost of Revenue||NZ$88.31m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||0.14|
|Net Profit Margin||4.94%|
How did CVT perform over the long term?See historical performance and comparison
1.1%Current Dividend Yield
Is Comvita undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: CVT (NZ$3.73) is trading above our estimate of fair value (NZ$1.04)
Significantly Below Fair Value: CVT is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: CVT is poor value based on its PE Ratio (27.6x) compared to the Global Personal Products industry average (26.1x).
PE vs Market: CVT is poor value based on its PE Ratio (27.6x) compared to the NZ market (22.2x).
Price to Earnings Growth Ratio
PEG Ratio: CVT is poor value based on its PEG Ratio (1.6x)
Price to Book Ratio
PB vs Industry: CVT is good value based on its PB Ratio (1.2x) compared to the XO Personal Products industry average (2.1x).
How is Comvita forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CVT's forecast earnings growth (17.8% per year) is above the savings rate (2.1%).
Earnings vs Market: CVT's earnings (17.8% per year) are forecast to grow faster than the NZ market (9.2% per year).
High Growth Earnings: CVT's earnings are forecast to grow, but not significantly.
Revenue vs Market: CVT's revenue (5.4% per year) is forecast to grow faster than the NZ market (5.3% per year).
High Growth Revenue: CVT's revenue (5.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CVT's Return on Equity is forecast to be low in 3 years time (6.7%).
How has Comvita performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CVT has high quality earnings.
Growing Profit Margin: CVT became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: CVT's earnings have declined by 34.2% per year over the past 5 years.
Accelerating Growth: CVT has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: CVT has become profitable in the last year, making it difficult to compare its past year earnings growth to the Personal Products industry (23%).
Return on Equity
High ROE: CVT's Return on Equity (4.3%) is considered low.
How is Comvita's financial position?
Financial Position Analysis
Short Term Liabilities: CVT's short term assets (NZ$154.3M) exceed its short term liabilities (NZ$31.4M).
Long Term Liabilities: CVT's short term assets (NZ$154.3M) exceed its long term liabilities (NZ$33.3M).
Debt to Equity History and Analysis
Debt Level: CVT's debt to equity ratio (9.4%) is considered satisfactory.
Reducing Debt: CVT's debt to equity ratio has reduced from 65.8% to 9.4% over the past 5 years.
Debt Coverage: CVT's debt is well covered by operating cash flow (119.1%).
Interest Coverage: CVT's interest payments on its debt are well covered by EBIT (6.3x coverage).
What is Comvita current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: CVT's dividend (1.07%) isn’t notable compared to the bottom 25% of dividend payers in the NZ market (2.41%).
High Dividend: CVT's dividend (1.07%) is low compared to the top 25% of dividend payers in the NZ market (4.9%).
Stability and Growth of Payments
Stable Dividend: CVT is not paying a notable dividend for the NZ market, therefore no need to check if payments are stable.
Growing Dividend: CVT is not paying a notable dividend for the NZ market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: CVT is not paying a notable dividend for the NZ market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of CVT's dividend in 3 years as they are not forecast to pay a notable one for the NZ market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. David Banfield has been the Chief Executive Officer of Comvita Limited since joining on January 20, 2020. Mr. Banfield has been a Director of Methven Limited since May 25, 2015 and serves as its Managi...
Experienced Management: CVT's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.
Experienced Board: CVT's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Comvita Limited's employee growth, exchange listings and data sources
- Name: Comvita Limited
- Ticker: CVT
- Exchange: NZSE
- Founded: 1974
- Industry: Personal Products
- Sector: Household
- Market Cap: NZ$261.361m
- Shares outstanding: 70.07m
- Website: https://www.comvita.co.nz
Number of Employees
- Comvita Limited
- 23 Wilson Road South
- Te Puke
- New Zealand
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/25 06:01|
|End of Day Share Price||2021/10/22 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.